Nasdaqcompany
DevelopingMarket movement

Ortex estimates 99% of MiniMed float sold short as short interest surges

Data provider Ortex estimated that 99% of MiniMed Group Inc.'s float was sold short, up sharply from prior levels.

Why it matters

The extreme short interest creates a potential short squeeze risk and reflects unusual market dynamics around the Medtronic spin-off and share exchange offer.

Key facts

Ortex estimated 99% of MiniMed Group Inc.'s float was sold short

99 %Reported by Protos

Short interest rose from 47.6% on September 15 and 77% a week earlier

47.6 %Reported by Protos

Available stock to borrow at 0.08% of short interest

0.08 %Reported by Protos

MiniMed was spun off from Medtronic in a March 2026 IPO

Reported by Protos

Medtronic owned 90% of MiniMed as of September 14

90 %Reported by Protos

Medtronic offered a tax-free exchange of MiniMed shares for Medtronic shares

Reported by Protos

What happened

Protos reported that Ortex estimated 99% of MiniMed Group Inc.'s float was sold short, a near-total shorting of available shares. Short interest had risen from 47.6% on September 15 and 77% a week earlier, with available stock to borrow at just 0.08% of short interest. MiniMed was spun off from Medtronic in a March 2026 IPO; Medtronic still owned 90% of MiniMed as of September 14 and was offering a tax-free exchange of MiniMed shares for Medtronic shares. The anomaly stems from this swap arrangement with a Friday deadline.

How the story developed

  1. First report

    First report by Protos

    How MiniMed ended up with 99% of its float sold short

    Protos

  2. Update

    Ortex reports 99% short interest in MiniMed

    Data provider Ortex estimates nearly the entire MiniMed float is sold short

    Protos

Affected entities

Original sources

PublisherReportRolePublished
Protos
Crypto media
How MiniMed ended up with 99% of its float sold shortOriginal